Disruption of MDM2-p53 Interactions by a Small Molecule Inhibitor RG7112 Increases Apoptosis and Impairs Polyploidization of Human Megakaryocytes

被引：1

作者：

Iancu-Rubin, Camelia ^{[1
]}

Goar, Mosoyan ^{[1
]}

Hoffman, Ronald ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.1082.1082

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1082

引用

页数：2

共 50 条

[1] Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis
Iancu-Rubin, Camelia
Mosoyan, Goar
Glenn, Kelli
Gordon, Ronald E.
Nichols, Gwen L.
Hoffman, Ronald
EXPERIMENTAL HEMATOLOGY, 2014, 42 (02) : 137 - 145
[2] Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
Vu, Binh
Wovkulich, Peter
Pizzolato, Giacomo
Lovey, Allen
Ding, Qingjie
Jiang, Nan
Liu, Jin-Jun
Zhao, Chunlin
Glenn, Kelli
Wen, Yang
Tovar, Christian
Packman, Kathryn
Vassilev, Lyubomir
Graves, Bradford
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (05): : 466 - 469
[3] MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
Tovar, Christian
Graves, Bradford
Packman, Kathryn
Filipovic, Zoran
Higgins, Brian
Xia, Mingxuan
Tardell, Christine
Garrido, Rosario
Lee, Edmund
Kolinsky, Kenneth
To, Kwong-Him
Linn, Michael
Podlaski, Frank
Wovkulich, Peter
Vu, Binh
Vassilev, Lyubomir T.
CANCER RESEARCH, 2013, 73 (08) : 2587 - 2597
[4] RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas
Obrador-Hevia, Antonia
Martinez-Font, Esther
Felipe-Abrio, Irene
Calabuig-Farinas, Silvia
Serra-Sitjar, Margalida
Antonio Lopez-Guerrero, Jose
Ramos, Rafael
Alemany, Regina
Martin-Broto, Javier
CANCER INVESTIGATION, 2015, 33 (09) : 440 - 450
[5] In Vitro Characterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell Lines
Al-Ghabkari, Abdulhameed
Narendran, Aru
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (04) : 252 - 257
[6] A new therapeutic combination in sarcomas: RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response
Obrador-Hevia, A.
Calabuig-Farinas, S.
Ramos, R.
Alemany, R.
Martin, J.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S891 - S892
[7] Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Andreeff, Michael
Kelly, Kevin R.
Yee, Karen
Assouline, Sarit
Strair, Roger
Popplewell, Leslie
Bowen, David
Martinelli, Giovanni
Drummond, Mark W.
Vyas, Paresh
Kirschbaum, Mark
Iyer, Swaminathan Padmanabhan
Ruvolo, Vivian
Gonzalez, Graciela M. Nogueras
Huang, Xuelin
Chen, Gong
Graves, Bradford
Blotner, Steven
Bridge, Peter
Jukofsky, Lori
Middleton, Steve
Reckner, Monica
Rueger, Ruediger
Zhi, Jianguo
Nichols, Gwen
Kojima, Kensuke
CLINICAL CANCER RESEARCH, 2016, 22 (04) : 868 - 876
[8] Pharmacodynamic Biomarkers in the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Andreeff, Michael
Kojima, Kensuke
Ruvolo, Vivian
Younes, Anas
Wei, Wei
Konopleva, Marina
Duvvuri, Seshagiri
Huang, Xuelin
Wu, Lin
Jukofsky, Lori
Vassilev, Lyubomir
Zhi, Jianguo
Geho, David
Nichols, Gwen
BLOOD, 2011, 118 (21) : 671 - 671
[9] Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
Verreault, Maite
Schmitt, Charlotte
Goldwirt, Lauriane
Pelton, Kristine
Haidar, Samer
Levasseur, Camille
Guehennec, Jeremy
Knoff, David
Labussiere, Marianne
Marie, Yannick
Ligon, Azra H.
Mokhtari, Karima
Khe Hoang-Xuan
Sanson, Marc
Alexander, Brian M.
Wen, Patrick Y.
Delattre, Jean-Yves
Ligon, Keith L.
Idbaih, Ahmed
CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1185 - 1196
[10] Small molecule inhibitors of the human MDM2-p53 interaction as anticancer agents
Wang, S.
Shangary, S.
Qin, Q.
McEachern, D.
Ding, K.
Nikolovska-Coleska, Z.
Lu, Y.
Malek, S.
Guo, M.
Yang, D.
EJC SUPPLEMENTS, 2008, 6 (12): : 83 - 83

← 1 2 3 4 5 →